Grace Therapeutics Inc. Common Stock (GRCE)
Stock · NASDAQ · Health Care
$2.13as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$2.26
Industry
Biotechnology: Pharmaceutical Preparations
About GRCE
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 5
- Website
- www.gracetx.com/
Fundamentals
- 1-day range
- $2.1$2.16
- Market cap
- $28.44M
- P/E (trailing)
- —
- P/E (forward)
- -3.84
- EPS (trailing)
- $-0.47
- Dividend yield
- —
- Beta
- 0.31
- Avg. volume
- 276.7K
52-week range
$1.79$5.18
Next earnings: June 20, 2025 · EPS estimate $-0.40
Forecasts
2 analyst ratings
Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$8.09
+279.7%
Median
$6.08
+185.3%
Low
$4.07
+91.0%
Grace Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- GRCEGrace Therapeutics Inc. Common Stock$2.13▼ 1.39%Market cap $28.44MP/E —$1.79$5.18
- MIRAMIRA Pharmaceuticals Inc. Common Stock$0.75▼ 2.60%Market cap $28.50MP/E —$0.6$2.45
- RMTIRockwell Medical Inc. Common Stock$8.22▲ 6.06%Market cap $28.26MP/E —$4.89$21
- KYNBKyntra Bio Inc. Common Stock$8.02▲ 1.26%Market cap $28.26MP/E 0.17$6.32$12.6
- ACTUActuate Therapeutics Inc. Common stock$1.67▼ 1.18%Market cap $29.43MP/E —$0.9$9.22
- ABVCABVC BioPharma Inc. Common Stock$0.8251▲ 3.66%Market cap $27.09MP/E —$0.7069$3.4
- BCTXBriaCell Therapeutics Corp. Common Shares$3.73▲ 0.54%Market cap $30.01MP/E —$3.68$20.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GRCE Grace Therapeutics Inc. Common Stock | $28.44M | — | $2.13 | ▼ 1.39% | $1.79$5.18 |
| MIRA MIRA Pharmaceuticals Inc. Common Stock | $28.50M | — | $0.75 | ▼ 2.60% | $0.6$2.45 |
| RMTI Rockwell Medical Inc. Common Stock | $28.26M | — | $8.22 | ▲ 6.06% | $4.89$21 |
| KYNB Kyntra Bio Inc. Common Stock | $28.26M | 0.17 | $8.02 | ▲ 1.26% | $6.32$12.6 |
| ACTU Actuate Therapeutics Inc. Common stock | $29.43M | — | $1.67 | ▼ 1.18% | $0.9$9.22 |
| ABVC ABVC BioPharma Inc. Common Stock | $27.09M | — | $0.8251 | ▲ 3.66% | $0.7069$3.4 |
| BCTX BriaCell Therapeutics Corp. Common Shares | $30.01M | — | $3.73 | ▲ 0.54% | $3.68$20.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Grace Therapeutics Files Prospectus For Offering 4.762M Common Shares On Behalf Of Selling Shareholdersbenzinga · 8/24/2026
- Grace Therapeutics Files Prospectus For Offering 4.762M Common Shares On Behalf Of Selling ShareholdersBenzinga · 8/24/2026
- Grace Therapeutics Q1 EPS $(0.91) Misses $(0.18) EstimateBenzinga · 8/13/2026
- Grace Therapeutics Announces $10 Million Private PlacementYahoo · 8/5/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 4.37M
- Total value held
- $20.23M
- Institutional holders
- 34
Top holders this quarter
- Unknown849.1K
- Unknown756.6K
- Unknown728.2K
- Unknown494.7K
- Unknown401.7K
- Unknown243.9K
- Unknown167.1K
- Unknown112.8K
- Unknown98.7K
- Unknown91.4K
See the full, filterable feed with live charts on the MarketWall dashboard.